Clinical Trial Update: Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating ZK 6032924 in probable Alzheimer's disease patients vs. healthy volunteers, with radiation dosimetry data reported in h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ZK 6032924

Snippet

Sponsor: Bayer | Conditions: Positron-Emission Tomography, Alzheimer's Disease | Phase 1 | Status: COMPLETED